Cite
A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.
MLA
Eve Draper, et al. “A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix(®) and Gardasil(®) Human Papillomavirus Vaccines in 12-15 Year Old Girls.” PLoS ONE, vol. 8, no. 5, Jan. 2013, p. e61825. EBSCOhost, https://doi.org/10.1371/journal.pone.0061825.
APA
Eve Draper, Sara L Bissett, Rebecca Howell-Jones, Pauline Waight, Kate Soldan, Mark Jit, Nicholas Andrews, Elizabeth Miller, & Simon Beddows. (2013). A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls. PLoS ONE, 8(5), e61825. https://doi.org/10.1371/journal.pone.0061825
Chicago
Eve Draper, Sara L Bissett, Rebecca Howell-Jones, Pauline Waight, Kate Soldan, Mark Jit, Nicholas Andrews, Elizabeth Miller, and Simon Beddows. 2013. “A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix(®) and Gardasil(®) Human Papillomavirus Vaccines in 12-15 Year Old Girls.” PLoS ONE 8 (5): e61825. doi:10.1371/journal.pone.0061825.